Laser Photonics Files S-1 for Resale of 3.87M Shares, Warrants at $3.40

TL;DR

**LASE's S-1 is a red flag for dilution, with selling stockholders offloading millions of shares and warrants, while insider control remains high.**

AI Summary

Laser Photonics Corp (LASE) is offering up to 3,871,964 shares of common stock for resale by selling stockholders, including 1,098,902 unregistered shares from a September 2025 Securities Purchase Agreement and shares issuable from associated warrants. The company will not receive proceeds from the stock sales but may receive cash from warrant exercises, with Series A and Placement Agent Warrants expiring in five years and Series B Warrants in eighteen months, all with an exercise price of $3.40 per share. LASE reported net revenues of $3.4 million by December 31, 2024, and has expanded into the pharmaceutical manufacturing vertical through the acquisition of Control Micro Systems, Inc. (CMS). The company is developing a Laser Shield Anti-Drone System (LSAD) with affiliate Fonon Technologies and has entered into several licensing agreements, including a perpetual, worldwide exclusive license for Laser Photonics™ branded equipment for a 6.5% royalty and a May 2024 agreement with Fonon Corporation for laser material processing technology in exchange for 3,000,000 restricted shares. Dmitriy Nikitin, through ICT Investments and its affiliates, holds significant voting control, with an aggregate ownership of approximately 44% of LASE's common stock after this offering.

Why It Matters

This S-1 filing signals a significant potential dilution event for existing LASE shareholders as up to 3,871,964 shares, including those from recent private placements and warrants, become eligible for resale. While the company won't directly benefit from the stock sales, the exercise of warrants could inject capital, which is crucial for a company with $3.4 million in net revenues by December 2024 and ambitious growth plans in laser technology. The substantial ownership and voting control by Dmitriy Nikitin and ICT Investments (44% post-offering) could influence strategic decisions, impacting minority investors. The expansion into the pharmaceutical manufacturing vertical via CMS and the development of the LSAD system highlight LASE's competitive positioning in specialized laser markets.

Risk Assessment

Risk Level: high — The offering of up to 3,871,964 shares by selling stockholders, including 1,098,902 unregistered shares and shares from warrants with an exercise price of $3.40, presents a significant risk of dilution for current shareholders. The company explicitly states it will not receive proceeds from the sale of these shares, only potentially from warrant exercises, which may not occur. Furthermore, Dmitriy Nikitin's aggregate ownership of approximately 44% of common stock post-offering grants him significant voting control, posing a risk to independent governance.

Analyst Insight

Investors should exercise extreme caution due to the potential for significant share dilution from the resale of 3,871,964 shares and warrants. Consider the impact of the $3.40 warrant exercise price relative to the current market price of $3.90, and the implications of Dmitriy Nikitin's 44% voting control. Await further financial disclosures to assess the company's ability to generate substantial revenue beyond the reported $3.4 million by December 31, 2024, before making any investment decisions.

Financial Highlights

debt To Equity

N/A

revenue

$3.4 million

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

N/A

eps

N/A

gross Margin

N/A

cash Position

N/A

revenue Growth

N/A

Revenue Breakdown

Key Numbers

• 3,871,964 — Shares of Common Stock (Maximum number of shares offered for resale by selling stockholders)
• $0.001 — Par Value per Share (Par value of Laser Photonics Corporation's common stock)
• 1,098,902 — Unregistered Shares (Shares issued under the September 2025 Securities Purchase Agreement)
• 1,098,902 — Shares Issuable from Series A Warrant (Shares potentially issued upon exercise of the unregistered long-term warrant)
• 1,098,902 — Shares Issuable from Series B Warrant (Shares potentially issued upon exercise of the unregistered short-term warrant)
• 76,923 — Shares Issuable from Placement Agent Warrants (Shares potentially issued upon exercise of private placement warrants to H.C. Wainwright & Co., LLC designees)
• 418,000 — Shares Issued to Hudson Global Ventures, LLC (Shares issued under the August 28, 2025 Hudson Global SPA)
• 157,258 — Shares Issuable from Hudson Warrant (Shares potentially issued upon exercise of the warrant under the Hudson Global SPA)
• $3.40 — Exercise Price per Share (Exercise price for Common Warrants and Placement Agent Warrants)
• $3.90 — Last Reported Sales Price (Price of LASE common stock on Nasdaq as of October 10, 2025)
• $3.4 million — Net Revenues (Net revenues by December 31, 2024)
• 6.5% — Royalty Rate (Royalty paid to ICT Investments for Laser Photonics™ branded equipment sales)
• $350,000 — License Fee (Cash payment for Cold Cutting laser cutting technology license from Fonon Technologies, Inc.)
• 1,000,000 — Restricted Shares (Shares granted to ICT Investments for Cold Cutting laser cutting technology license)
• 3,000,000 — Restricted Shares (Shares granted to Fonon Corporation for laser material processing equipment license)
• 44% — Aggregate Ownership (Percentage of common stock owned by ICT Investments and its affiliates post-offering)

Key Players & Entities

• Laser Photonics Corp (company) — Registrant and issuer of securities
• Wayne Tupuola (person) — CEO of Laser Photonics Corp
• Ernest M. Stern (person) — Legal counsel from CM Law PLLC
• H.C. Wainwright & Co., LLC (company) — Placement Agent for the September 2025 Purchase Agreement
• Hudson Global Ventures, LLC (company) — Investor in a note financing and recipient of 418,000 shares and the Hudson Warrant
• ICT Investments, LLC (company) — Affiliate and significant shareholder, holding approximately 20% of outstanding shares and controlling other affiliates
• Fonon Technologies, Inc. (company) — Affiliate and partner in LSAD development, owning approximately 3% of outstanding shares
• Fonon Corporation (company) — Affiliate and licensor of laser material processing equipment, owning approximately 13% of outstanding shares
• Dmitriy Nikitin (person) — Has voting control of the Company through ownership of ICT Investments
• Control Micro Systems, Inc. (company) — Acquired company, expanding LASE's market into pharmaceutical manufacturing

FAQ

Risk Factors

• Reliance on Selling Stockholders and Potential Dilution [medium — financial]: The offering involves the resale of up to 3,871,964 shares by selling stockholders, not for the benefit of the company. While the company may receive cash from warrant exercises at $3.40 per share, the primary purpose is to allow existing holders to sell shares, potentially increasing the supply of stock and exerting downward pressure on the stock price.
• Dependence on Key Affiliates and Licensing Agreements [medium — operational]: The company's development of the Laser Shield Anti-Drone System (LSAD) relies on affiliate Fonon Technologies. Furthermore, significant revenue streams are tied to licensing agreements, such as the 6.5% royalty on Laser Photonics™ branded equipment sales and a recent agreement with Fonon Corporation for laser material processing technology in exchange for 3,000,000 restricted shares. Disruptions or disputes in these relationships could materially impact operations and revenue.
• Unregistered Shares and Compliance [low — regulatory]: A significant portion of the shares offered, 1,098,902, are unregistered shares from a September 2025 Securities Purchase Agreement. The company must ensure compliance with all SEC regulations regarding the resale of these shares and any shares issued upon warrant exercise to avoid potential penalties or legal challenges.
• Competition in Laser Technology and Defense Sectors [medium — market]: Laser Photonics Corp operates in competitive markets, including industrial lasers and potentially defense (with the LSAD system). The success of its products and technologies depends on its ability to innovate and compete effectively against established players and emerging technologies.
• Limited Operating History and Revenue [medium — financial]: With net revenues of $3.4 million by December 31, 2024, the company is still in its early stages of revenue generation. Profitability and sustainable growth are not yet demonstrated, making it susceptible to market fluctuations and operational challenges.

Industry Context

Laser Photonics Corp operates in the industrial laser market, which is characterized by technological advancements and increasing demand across various sectors like manufacturing, healthcare, and defense. The company is also venturing into the pharmaceutical manufacturing vertical and developing defense-related technology (LSAD), indicating a strategy to diversify its market reach within the broader photonics and advanced materials industries.

Regulatory Implications

The filing of this S-1 as a resale prospectus highlights the need for strict adherence to SEC regulations regarding the sale of securities. The presence of unregistered shares and various warrants necessitates careful management of compliance to avoid potential legal issues and ensure orderly trading.

What Investors Should Do

1. Analyze Selling Stockholder Intent
2. Evaluate Warrant Dilution Potential
3. Scrutinize Licensing and Affiliate Agreements
4. Monitor Revenue Growth and Profitability

Key Dates

• 2024-12-31: Reported Net Revenues — Indicates the company's revenue generation as of the end of the fiscal year.
• 2025-09-01: Securities Purchase Agreement — Resulted in the issuance of 1,098,902 unregistered shares, which are part of the current resale offering.
• 2024-05-01: Agreement with Fonon Corporation — Granted a license for laser material processing technology in exchange for 3,000,000 restricted shares, impacting share structure and potential dilution.

Glossary

Resale Prospectus

A registration statement filed with the SEC that allows existing security holders to sell their shares to the public. (This S-1 filing is a resale prospectus, meaning the company itself is not raising capital, but rather existing stockholders are offering their shares for sale.)

Warrants

Securities that give the holder the right, but not the obligation, to purchase a company's stock at a predetermined price (exercise price) within a specified timeframe. (LASE has various warrants outstanding (Series A, Series B, Placement Agent, Hudson Warrant) with an exercise price of $3.40, which could lead to the issuance of new shares and potential dilution.)

Restricted Shares

Shares of stock that have limitations on when and how they can be sold, often issued as compensation or in private placements. (LASE has issued restricted shares to ICT Investments and Fonon Corporation as part of licensing agreements, impacting the total number of shares and ownership structure.)

Securities Purchase Agreement (SPA)

A contract between a buyer and a seller that details the terms and conditions of a securities transaction. (The S-1 references shares from a September 2025 SPA and an August 28, 2025 SPA with Hudson Global Ventures, LLC, indicating past private financing activities.)

Year-Over-Year Comparison

This S-1 filing focuses on the resale of shares by existing stockholders and does not appear to be a direct comparison to a prior S-1 filing for a primary offering. Key metrics like revenue ($3.4 million by Dec 31, 2024) and the significant number of shares being offered for resale (up to 3,871,964) are central to this filing. New risks related to the resale of unregistered shares and the exercise of various warrants are highlighted, alongside the company's expansion into new verticals and reliance on affiliate relationships.

Key Financial Figures

• $0.001 — res”), of common stock, par value $0.001 per share (“Common Stock”),
• $455,000 — te financing in the principal amount of $455,000 and (f) shares issuable under a warrant
• $4.34 — f Common Stock at a conversion price of $4.34 per share subject to customary adjustme
• $3.40 — d hereby will have an exercise price of $3.40 per share and will be exercisable upon
• $3.90 — ted sales price of our common stock was $3.90 per share. We are an “emerging
• $3.4 million — cember 31, 2024, we had net revenues of $3.4 million. We are strategically positioned to dri
• $350,000 — return for our paying a license fee of $350,000 in cash and a one-time grant of 1,000,0
• $14,818.06 — ber 31, 2025, at a base monthly rent of $14,818.06 (“Suite 125”). In light of
• $14,912.14 b — eed to pay a monthly termination fee of $14,912.14 base rent plus operating expenses for fiv
• $80,000 — or five months, saving us approximately $80,000 in lease payments for 2025. 4 On Ju
• $2,100,000 — a term loan in the principal amount of $2,100,000 with total interest of $924,000 (the &l
• $924,000 — nt of $2,100,000 with total interest of $924,000 (the “Loan”) to be repaid t
• $94,500 — ekly principal and interest payments of $94,500 commencing July 16, 2025, and ending Fe
• $100,000 — ruary 18, 2026, subject to payment of a $100,000 administrative agent fee paid to Agile

Filing Documents

• forms-1.htm (S-1) — 327KB
• ex5-1.htm (EX-5.1) — 13KB
• ex23-1.htm (EX-23.1) — 5KB
• ex23-2.htm (EX-23.2) — 4KB
• ex107.htm (EX-FILING FEES) — 36KB
• ex23-1_001.jpg (GRAPHIC) — 23KB
• ex23-1_002.jpg (GRAPHIC) — 9KB
• ex23-2_001.jpg (GRAPHIC) — 11KB
• 0001493152-25-018029.txt ( ) — 569KB
• ex107_htm.xml (XML) — 6KB

Use of Proceeds

Use of Proceeds 9 Dividend Policy 9 Selling Stockholders 9 Description of The Securities That the Selling Stockholders Are Offering 12 Plan of Distribution 15 Legal Matters 16 Experts 17 Where You Can Find Additional Information 17 Incorporation of Certain Documents by Reference 17 i ABOUT THIS PROSPECTUS This prospectus describes the general manner in which the Selling Stockholders may offer from time to time up to 3,871,964 Shares (i) issued directly to the Selling Stockholders pursuant to the Securities Purchase Agreement or (ii) issuable upon the exercise of the Common Warrants issued pursuant to the Securities Purchase Agreement. You should rely only on the information contained in this prospectus and the related exhibits, any prospectus supplement or amendment thereto and the documents incorporated by reference, or to which we have referred you, before making your investment decision. Neither we nor the Selling Stockholders have authorized anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. This prospectus, any prospectus supplement or amendments thereto do not constitute an offer to sell, or a solicitation of an offer to purchase, the Shares offered by this prospectus, any prospectus supplement or amendments thereto in any jurisdiction to or from any person to whom or from whom it is unlawful to make such offer or solicitation of an offer in such jurisdiction. You should not assume that the information contained in this prospectus, any prospectus supplement or amendments thereto, as well as information we have previously filed with the U.S. Securities and Exchange Commission, or the SEC, is accurate as of any date other than the date on the front cover of the applicable document. If necessary, the specific manner in which the Shares may be offered and sold will be described in a supplement to this prospectus, which supplement may also a

View Full Filing

View this S-1 filing on SEC EDGAR